← All Ani Pharmaceuticals INC filings

Ani Pharmaceuticals INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
ANIP
Ani Pharmaceuticals INC
SCHEDULE: Meridian Venture Partners Updates ANI Pharma Stake
Meridian Venture Partners and Robert E. Brown, Jr. updated their beneficial ownership in ANI Pharmaceuticals, Inc., collectively holding 4.8% of common stock.
NASDAQ
ANIP
Ani Pharmaceuticals INC
SCHEDULE 13D/A: Meridian Venture Partners Reduces Stake in ANI Pharmaceuticals, Sells 50,000 Shares
Meridian Venture Partners and affiliated entities, along with Robert E. Brown, Jr., have filed an amended Schedule 13D, disclosing the sale of 50,000 shares of ANI Pharmaceuticals, Inc. common stock for investment purposes.